Device: HemoSphere monitor and Acumen IQ sensor.: Patients will be placed on this monitor for the duration of study in the PACU. Followed by 30-day phone call to record cardiovascular complications.
Study summary
PACU-HPI study evaluates the use of a hemodynamic monitor in the post-anesthetic recovery room on patients undergoing colorectal, hepatobiliary, and vascular surgery, to determine the feasibility of recruiting this surgical population.
Eligibility
Sex
ALL
Min age
45 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patient ≥45 years old
2. Will undergo open colorectal, hepatobiliary, or vascular surgery;
3. Is expected to have an arterial cannula inserted intraoperatively;
4. Has an anticipated stay in PACU for at least 2 hours;
5. Able to provide written informed consent
Exclusion Criteria:
1. Planned admission to ICU;
2. Refusal to participate;
3. Previously enrolled in the study
Primary outcome measure(s)
Incidence of intraoperative hypotension — in 12 months Describe the incidence of hypotension defined as MAP \<65 intraoperatively.
Incidence of postoperative hypotension — in 12 months Describe the incidence of postoperative hypotension defined as MAP \<65 in the PACU
Hemodynamic changes with treatment of hypotension — in 12 months Described the changes in cardiac index with each medical treatment of a hypotensive episode.
Trial sites (1)
Facility
City
Region
Status
Jewish General Hospital, Anesthesia Department
Montreal
Quebec
Recruiting
More Sir Mortimer B. Davis - Jewish General Hospital trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.